Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased Tuberculosis Incidence Due to Immunotherapy Based on PD-1 and PD-L1 Blockade: A Systematic Review and Meta-Analysis
Kewei Liu, Dongpo Wang, Cong Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Showing 23 citing articles:

Recent advances in understanding the human host immune response in tuberculous meningitis
James Barnacle, Angharad Davis, Robert J. Wilkinson
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
Where lung cancer and tuberculosis intersect: recent advances
Chunju Fang, Xuanlu He, Fei Tang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis
Qi An, Rui Lin, Qing Yang, et al.
Journal of Global Antimicrobial Resistance (2023) Vol. 34, pp. 214-226
Open Access | Times Cited: 10
Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections
Kohei Fujita, Paul Elkington
Respiratory Investigation (2024) Vol. 62, Iss. 3, pp. 339-347
Closed Access | Times Cited: 3
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions
Ling Yang, Zhuang Li, Zhaoyang Ye, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107881-107881
Open Access | Times Cited: 9
Fever of unknown origin associated with immune checkpoint inhibitors
Tong Xu, Tao Zhan, Xiaoqin Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Distinguish active tuberculosis with an immune-related signature and molecule subtypes: a multi-cohort analysis
Qingqing Shan, Yangke Li, Kun Yuan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Absence of PD-L1 signaling hinders macrophage defense against Mycobacterium tuberculosis via upregulating STAT3/IL-6 pathway
Peijie Qu, Xinyu Li, Weihuang Liu, et al.
Microbes and Infection (2024) Vol. 26, Iss. 5-6, pp. 105352-105352
Closed Access | Times Cited: 1
Dual neutrophil subsets exacerbate or suppress inflammation in tuberculosis via IL-1β or PD-L1
Emilie Doz, Badreddine Bounab, Florence Carreras, et al.
Life Science Alliance (2024) Vol. 7, Iss. 7, pp. e202402623-e202402623
Open Access | Times Cited: 1
PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person With HIV
Li Liu, Zichen Song, Jingna Xun, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Immune Checkpoint Inhibitors and Tuberculosis Infection in Lung Cancer: A Case Series and Systematic Review With Pooled Analysis
Yanqing He, Duanyang Peng, Liang Ping-an, et al.
The Journal of Clinical Pharmacology (2022) Vol. 63, Iss. 4, pp. 397-409
Closed Access | Times Cited: 3
Reativação de Tuberculose Pulmonar em uma Paciente com Câncer de Orofaringe Tratada com Nivolumabe: Relato de Caso
Fernanda Navarro Loiola, Henrique Zanoni Fernandes
Revista Brasileira de Cancerologia (2024) Vol. 69, Iss. 4
Open Access
Progress in mechanism-based diagnosis and treatment of tuberculosis comorbid with tumor
Chuan Wang, Rong-Qi Zou, Guozhong He
Frontiers in Immunology (2024) Vol. 15
Open Access
Lung cancer and pulmonary tuberculosis: key features of molecular mechanisms of concomitant disease
G. M. Agafonov, Grigorii Kudriashov, U. S. Krylova, et al.
Успехи физиологических наук (2024) Vol. 55, Iss. 3, pp. 58-74
Closed Access
HLA-E/Mtb specific CD4+ and CD8+ T cells have a memory phenotype in individuals with TB infection
Linda Voogd, Catherine Riou, Thomas J. Scriba, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
Ranferi Ocaña‐Guzmán, Diego Osorio-Pérez, Leslie Chávez‐Galán
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1119-1119
Open Access | Times Cited: 1
Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
Shiqi Hu, Xiaojuan Lin, Rutie Yin, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34548-e34548
Open Access | Times Cited: 1
Diagnostic and therapeutic approach to pulmonary infiltrates in cancer patients receiving immune checkpoint inhibitors
Mario Fernández‐Ruiz
Revista Española de Quimioterapia (2022) Vol. 35, Iss. Suppl3, pp. 67-73
Open Access | Times Cited: 1
Protecting the most vulnerable: tuberculosis in immunocompromised individuals
Egídio Torrado, Reinout vanCrevel, Ana Raquel Afonso, et al.
European Respiratory Society eBooks (2023)
Closed Access
Neutrophil subsets play dual roles in tuberculosis by producing inflammasome dependent-IL-1β or suppressing T-cells via PD-L1
Emilie Doz, Badreddine Bounab, Florence Carreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Neutrophil subsets play dual roles in tuberculosis by producing inflammasome dependent-IL-1β or suppressing T-cells via PD-L1
Nathalie Winter, Emilie Doz, Badreddine Bounab, et al.
Research Square (Research Square) (2023)
Open Access
Acute Tuberculosis Infection Concomitant with Nivolumab Treatment in a Patient with Non-small Cell Lung Cancer: A Case Report and Review of the Literature
Edvina E Pîrvu
Journal of Medical and Radiation Oncology (2022) Vol. 2, Iss. 2, pp. 59-65
Open Access
Page 1

Scroll to top